Effect of heterologous intranasal iNCOVACC® vaccination as a booster to two-dose intramuscular Covid-19 vaccination series: a randomized phase 3 clinical trial
These findings demonstrate that impact of booster across different cohorts is governed by infection status of the individual and geographical diversity, thus necessitating large cohorts, well distributed studies before Covid-19 booster effects are interpreted.
Authors
- Amit Suresh Bhate
- Shivaraj K. K
- K. Sanjay (ORCID: https://orcid.org/0000-0002-6107-0673)
- Ajeet Singh (ORCID: https://orcid.org/0000-0002-4121-7834)
- Chandramani Singh (ORCID: https://orcid.org/0000-0002-5568-7036)
- Krishna Mohan Vadrevu
- Anil Pandey
- Jitendra Singh Kushwaha
- Venkateshwar Rao Akula
- Chandrasekhar S Gillurkar
Institutions
- Jehangir Hospital (IN)
- Max Super Speciality Hospital (IN)
- Midas Multispeciality Hospital (IN)
- Bharat Biotech (India) (IN)
- St. Theresa’s Multi-Speciality Hospital (IN)
- ESIC Hospital (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1038/s43856-025-00818-6
- Citations
- 6
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 8.38
Funders
- National Institute of Immunology
- Biotechnology Industry Research Assistance Council